Astellas Confirms Unfavorable District Court Decision in Myrbetriq ® US Patent Trial

ESG / By

Astellas’ ESG Initiatives · Financial Information · IR Library · Business Results · Overview of R&D Pipeline · IR Meetings …

Read More 

Related Posts

Leave a Comment

Your email address will not be published. Required fields are marked *